Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison during BIS-guided total intravenous anesthesia for endoscopic transsphenoidal pituitary adenoma resection
PACTR202608468388313Completed
- Sponsor
- Mansoura University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine in pituitary adenoma (3 arms), sponsored by Mansoura University. Primary endpoint: Total propofol consumption. Started Oct 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pituitary adenoma
Beyond the preview
Go deeper on PACTR202608468388313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608468388313.